Skip to main content
. 2022 Nov 24;14(23):4992. doi: 10.3390/nu14234992

Table 3.

List of hepatic lipid metabolism model parameters proposed by Pratt et al. [35].

Parameter Value
1. αA (adipose tissue volume) 15.60 L
2. αL (liver tissue volume) 1.60 L
3. αM (skeletal muscle volume) 26.4 L
4. β6 (rate of liver de novo lipogenesis from pyruvate) 31.6 L/min
6. βf (adipose release of triacylglycerides to non-esterified fatty acids) 0.117 mmol/min
7. βL (liver glycogenolysis) 12 L/min
8. βm (muscle glycogenolysis) 82.5 L/min
9. µamp (national adenosine monophosphate/adenosine diphosphate creation rate) 1.8
10. µb (lactate production by red blood cells) 0.133 mmol/min
11. µe (muscle triglyceride breakdown to free fatty acids) 0.420 mmol/min
12. µs (muscle free fatty acid esterification to triglycerides) 7.19 × 106 L mmol/min
13. µ1 (plasma glucose usage) 0.588 mmol/min
14. µ3 (muscle glucose-6-phospahte usage) 7.839 × 107 L mmol/min
15. µ4 (muscle free fatty acid usage) 100 L/min
16. c0 (small parameters) 0.1 mmol/L
17. cc (range of glucose concentrations over which excess insulin secretion occurs) 2.5 mmol/L
18. dba (adipose uptake of glucose) 0.3 mmol/min
19. k10 (affinity for hydrolysis of triglycerides to secretory pool) 0.625 mmol/L
20. k11 (basal insulin secretion rate) 48 mmol/min
21. k12 (increased fraction of very low-density lipoprotein 1 secretion by insulin) 0.2
22. k13 (rate at which insulin modifies the fraction of very low-density lipoprotein 1 to very low-density lipoprotein 2 secretion) 15 mmol/L
23. k14 (basal very low-density lipoprotein 1 secretion fraction) 0.6
24. k22 (excess insulin secretion rate due to glucose stimulation) 48 mmol/min
25. k5 (flux control coefficient for insulin inhibition of free fatty acid oxidation) 8.23 × 107/mmol
26. k6 (affinity for very low-density lipoprotein 2 triglyceride secretion through secretory pathway) 0.3 mmol/L
27. k61 (liver glucose dephosphorylation rate) 4 L/min
28. k6p (muscle glucose-6-phospahte to pyruvate conversion rate) 6.56 × 108 L2/mmol min
29. k7 (maximum rate of free fatty acid oxidation) 0.759 L/min
30. k8 (affinity for esterification of free fatty acids to triglycerides) 0.625 mmol/L
31. k9 (affinity of additional bulk lipidation) 43.583 mmol/L
32. k9a (release of very low-density lipoproteins from secretory pathway) 1 L/min
33. ka (adipose free fatty acid uptake of chylomicron triglycerides, insulin independent) 0.1497 L/min
34. kaa (adipose free fatty acid esterification to triglycerides) 3.11 × 105 L2/mmol min
35. kai (adipose free fatty acid uptake of chylomicron triglycerides, insulin dependent) 2.08 × 106 1/mmol
36. kal (pyruvate to acetyl coenzyme A conversion rate) 0.00002 L2/mmol min
37. kba (adipose uptake of endogenous lipoprotein triglycerides) 0.0104 L/min
38. kbl (liver uptake of plasma non-esterified fatty acids) 0.156 L/min
39. kbm (muscle uptake of plasma non-esterified fatty acids) 0.226 L/min
40. kcl (liver free fatty acid uptake of chylomicron triglycerides) 0.0075 L/min
41. kcm (muscle free fatty acid uptake of chylomicron triglycerides) 0.0449 L/min
42. kd (insulin degradation rate) 1.733 × 1014 L/mmol
43. kdl (liver glycogenolysis; insulin-inhibited rate) 3.5 × 188 mmol/L
44. kdy (muscle glycogenolysis; insulin-inhibited rate) 4 × 108 L/mmol
45. kft (adipose release of triglyceride to non-esterified fatty acids; insulin-inhibited rate) 1.67 × 1014 L/mmol
46. kga (rate of glucose diffusion between plasma and adipose mediated by glucose 4 transporters) 1.67 × 106
47. kgi (glucose diffusion between plasma and muscles, insulin-mediated) 2.632 × 108 mmol/L
48. kgl (plasma glucose diffusion rate to liver) 0.9277 mmol/L
49. kgl2 (live glucose diffusion rate to blood) 0.396 mmol/L
50. kgm (plasma glucose diffusion rate to muscle) 0.0380 mmol/L
51. kgm2 (muscle glucose diffusion rate to plasma) 0.0380 mmol/L
52. kgp (glucose-6-phospahte uptake from adipose glycerol) 0.311 L/min
53. klp (rate of plasma triglyceride uptake by adipose tissue) 0.25
54. kLG (Michaelis–Menten constant of glucokinase in liver) 8.95 mmol/L
55. kLH (Michaelis–Menten constant of hexokinase in liver) 0.0115 mmol/L
56. kMH (Michaelis–Menten constant of hexokinase in muscle) 8.98 mmol/L
57. kna (rate of plasma free fatty acid uptake into adipose free fatty acids) 0.0697 L/min
58. kp (rate of insulin-mediated glucose-6-phoshate to pyruvate) 1.41 × 107 mmol/L
59. kp6 (constant of pyruvate conversion to glucose-6-phospate) 6.56 × 108 L2/mmol min
60. kpp (rate of muscle pyruvate transport to liver) 0.5
61. kr (rate of endogenously derived lipoprotein triglycerides by liver as free fatty acids) 0.00058 mmol
62. krep (glucose-6-phospahte inhibition constant of hexokinase in muscle) 2.98 mmol/L
63. kt (uptake rate of plasma endogenous triglycerides into muscle free fatty acids) 0.00348 mmol/L
64. kyl (rate of the glycogen synthesis stimulated by insulin) 1.28 × 106
65. kym (glycogen synthesis rate) 21.3641 mmol/L
66. lmax (maximum glycogen store of liver) 400 mmol
67. mmax (maximum glycogen concentration) 100 mmol
68. v (rate of glycogen transport) 7 mmol
69. v10 (rate of triglyceride storage conversion to free fatty acids) 0.1 mmol/min
70. v12 (constant in triglyceride release into plasma) 40 mmol L−1
71. v6 (rate of liver free fatty acid input to secretory pool) 0.0158 mmol/L
72. v8 (rate of free fatty acid input to storage pool) 0.333 mmol/min
73. v9 (rate of triglyceride release into plasma)) 0.0159 mmol/L
74. vLG (maximum rate of glucokinase in liver) 14.3 mmol/min
76. vLH (maximum rate of hexokinase in liver) 5.57 mmol/min
76. vMH (muscle hexokinase maximum rate) 54.288 mmol/min
77. y0 (range of liver glycogen concentration over which the release drops to zero) 0.1
78. αG (rate of glucose change in diet) 2 mmol
79. αF (rate of fructose change in diet) 2 mmol/L
80. ms (insulin-dependent rate of skeletal muscle storage of free fatty acids in the form of triglycerides) 0.8
81. me (rate of skeletal muscle triglyceride breakdown to free fatty acids) 0.9